Echocardiographic Parameter and Sleep Apnea Changes After Mitral Valve Surgery (MitralHDZ)
Primary Purpose
Sleep Apnea
Status
Completed
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
Echocardiographic and sleep apnea test
Sponsored by
About this trial
This is an interventional diagnostic trial for Sleep Apnea focused on measuring mitral valve, valve surgery, echocardiography
Eligibility Criteria
Inclusion Criteria:
- mitral valve defect
- NYHA II-IV
- no additional cardiac surgical procedure
Exclusion Criteria:
- Pregnancy
- lung disease
- regular follow-up in the study Center in the first 6 months after surgery not guaranteed
- congenital heart disease
Sites / Locations
- Heart and Diabetes Center North Rhine-Westphalia
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Echocardiographic and sleep apnea test
Arm Description
Echocardiographic Evaluation of systolic and diastolic function of both ventricles and evaluation of apnea-hypopnea index and type of apnea
Outcomes
Primary Outcome Measures
Changes of left ventricular systolic function
Changes of apnea-hypopnea index
Changes of global longitudinal strain
Changes of right ventricular systolic function
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT02296710
Brief Title
Echocardiographic Parameter and Sleep Apnea Changes After Mitral Valve Surgery
Acronym
MitralHDZ
Official Title
Echocardiographic Parameter and Sleep Apnea Changes After Mitral Valve Surgery
Study Type
Interventional
2. Study Status
Record Verification Date
March 2017
Overall Recruitment Status
Completed
Study Start Date
August 2014 (undefined)
Primary Completion Date
May 2015 (Actual)
Study Completion Date
March 1, 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Zisis Dimitriadis
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The investigators evaluate the changes of echocardiographic and sleep apnea parameters after mitral valve surgery. The patients undergo echocardiographic and sleep apnea control before surgery. After a period of 3-5 months, they undergo a second echocardiographic and sleep apnea control and the results are evaluated.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sleep Apnea
Keywords
mitral valve, valve surgery, echocardiography
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
132 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Echocardiographic and sleep apnea test
Arm Type
Experimental
Arm Description
Echocardiographic Evaluation of systolic and diastolic function of both ventricles and evaluation of apnea-hypopnea index and type of apnea
Intervention Type
Procedure
Intervention Name(s)
Echocardiographic and sleep apnea test
Intervention Description
Echocardiographic evaluation (Vivid 7, GE) of systolic and diastolic function of both ventricles as well as evaluation of apnea-hypopnea index and type of apnea (ApneaLink®)
Primary Outcome Measure Information:
Title
Changes of left ventricular systolic function
Time Frame
1-4 weeks before and 3 months after surgery
Title
Changes of apnea-hypopnea index
Time Frame
1-4 weeks before and 3 months after surgery
Title
Changes of global longitudinal strain
Time Frame
1-4 weeks before and 3 months after surgery
Title
Changes of right ventricular systolic function
Time Frame
1-4 weeks before and 3 months after surgery
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
mitral valve defect
NYHA II-IV
no additional cardiac surgical procedure
Exclusion Criteria:
Pregnancy
lung disease
regular follow-up in the study Center in the first 6 months after surgery not guaranteed
congenital heart disease
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Zisis Dimitriadis, MD
Organizational Affiliation
Clinic for Cardiology, Heart and Diabetes Center North Rhine-Westphalia
Official's Role
Principal Investigator
Facility Information:
Facility Name
Heart and Diabetes Center North Rhine-Westphalia
City
Bad Oeynhausen
ZIP/Postal Code
32545
Country
Germany
12. IPD Sharing Statement
Learn more about this trial
Echocardiographic Parameter and Sleep Apnea Changes After Mitral Valve Surgery
We'll reach out to this number within 24 hrs